South Shore Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,162	Closed	-$385K	–	104
2021 Q1	$385K	Hold	3,162	–	–	0.38%	74
2020 Q4	$484K	Buy	+3,162	New	+$484K	0.48%	53